Header Logo

Connection

Jeff Slezak to Aged

Back to Details
This is a "connection" page, showing publications Jeff Slezak has written about Aged.
Jeff Slezak
Connection Strength
0.994
Aged
  1. Long-term follow-up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment. Cancer Med. 2020 11; 9(22):8530-8539.
    View in: PubMed
    Score: 0.084
  2. The Relationship Between Nonsteroidal Anti-inflammatory Drug Use and Age-related Macular Degeneration. Am J Ophthalmol. 2018 04; 188:111-122.
    View in: PubMed
    Score: 0.070
  3. Risk factors for locoregional recurrence after mastectomy in stage T1 N0 breast cancer. Am J Clin Oncol. 2014 Oct; 37(5):486-91.
    View in: PubMed
    Score: 0.056
  4. Potentially Harmful Medication Dispenses After a Fall or Hip Fracture: A Mixed Methods Study of a Commonly Used Quality Measure. Jt Comm J Qual Patient Saf. 2022 Apr; 48(4):222-232.
    View in: PubMed
    Score: 0.023
  5. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet. 2021 10 16; 398(10309):1407-1416.
    View in: PubMed
    Score: 0.023
  6. Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria. J Urol. 2021 May; 205(5):1387-1393.
    View in: PubMed
    Score: 0.021
  7. Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection. J Infect Dis. 2020 09 14; 222(8):1298-1310.
    View in: PubMed
    Score: 0.021
  8. Cost of Hospitalization Associated With Respiratory Syncytial Virus Infection Versus Influenza Infection in Hospitalized Older Adults. J Infect Dis. 2020 08 17; 222(6):962-966.
    View in: PubMed
    Score: 0.021
  9. Salvage Cryoablation for Radiorecurrent Prostate Cancer: Initial Experience at a Regional Health Care System. Perm J. 2019; 23.
    View in: PubMed
    Score: 0.019
  10. Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects. Muscle Nerve. 1997 Dec; 20(12):1561-8.
    View in: PubMed
    Score: 0.017
  11. Health-related quality of life outcomes from a contemporary prostate cancer registry in a large diverse population. BJU Int. 2017 10; 120(4):520-529.
    View in: PubMed
    Score: 0.017
  12. Ten-Year Trends in Preventive Service Use Before and After Prostate Cancer Diagnosis: A Comparison with Noncancer Controls. Perm J. 2017; 21:16-184.
    View in: PubMed
    Score: 0.016
  13. Treatment results of brachytherapy vs. external beam radiation therapy for intermediate-risk prostate cancer with 10-year followup. Brachytherapy. 2016 Nov - Dec; 15(6):687-694.
    View in: PubMed
    Score: 0.016
  14. Kaiser Permanente Creatinine Safety Program: A Mechanism to Ensure Widespread Detection and Care for Chronic Kidney Disease. Am J Med. 2015 Nov; 128(11):1204-1211.e1.
    View in: PubMed
    Score: 0.015
  15. Association between cannabis use and the risk of bladder cancer: results from the California Men's Health Study. Urology. 2015 Feb; 85(2):388-92.
    View in: PubMed
    Score: 0.014
  16. Progression and treatment of incident lower urinary tract symptoms (LUTS) among men in the California Men's Health Study. BJU Int. 2015 Jan; 115(1):127-33.
    View in: PubMed
    Score: 0.014
  17. Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus 'X'. Radiat Oncol. 2014 Jul 29; 9:171.
    View in: PubMed
    Score: 0.014
  18. Effects of physical activity and sedentary time on the risk of heart failure. Circ Heart Fail. 2014 Jan; 7(1):21-7.
    View in: PubMed
    Score: 0.013
  19. Predictors of early postoperative outcomes in 375 consecutive hepatectomies: a single-institution experience. Am Surg. 2013 Oct; 79(10):961-7.
    View in: PubMed
    Score: 0.013
  20. Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin Proc. 2013 Feb; 88(2):129-38.
    View in: PubMed
    Score: 0.012
  21. Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study. Vaccine. 2012 Aug 17; 30(38):5625-30.
    View in: PubMed
    Score: 0.012
  22. The Kaiser Permanente experience with ultrasound-guided percutaneous endovascular abdominal aortic aneurysm repair. Ann Vasc Surg. 2012 Oct; 26(7):906-12.
    View in: PubMed
    Score: 0.012
  23. Preventive care and health behaviors among overweight/obese men in HMOs. Am J Manag Care. 2012 Jan; 18(1):25-32.
    View in: PubMed
    Score: 0.012
  24. Population-based study of erectile dysfunction and polypharmacy. BJU Int. 2012 Jul; 110(2):254-9.
    View in: PubMed
    Score: 0.011
  25. Impact of median lobe anatomy: does its presence affect surgical margin rates during robot-assisted laparoscopic prostatectomy? J Endourol. 2012 May; 26(5):457-60.
    View in: PubMed
    Score: 0.011
  26. Association of hematuria on microscopic urinalysis and risk of urinary tract cancer. J Urol. 2011 May; 185(5):1698-703.
    View in: PubMed
    Score: 0.011
  27. Regular nonsteroidal anti-inflammatory drug use and erectile dysfunction. J Urol. 2011 Apr; 185(4):1388-93.
    View in: PubMed
    Score: 0.011
  28. Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA. 2010 May 05; 303(17):1699-706.
    View in: PubMed
    Score: 0.010
  29. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. J Urol. 2009 Aug; 182(2):517-25; discussion 525-7.
    View in: PubMed
    Score: 0.010
  30. Mortality, dementia, and apolipoprotein E genotype in elderly white women in the United States. J Am Geriatr Soc. 2009 Feb; 57(2):231-6.
    View in: PubMed
    Score: 0.009
  31. Alcoholic beverage intake and risk of lung cancer: the California Men's Health Study. Cancer Epidemiol Biomarkers Prev. 2008 Oct; 17(10):2692-9.
    View in: PubMed
    Score: 0.009
  32. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer. BJU Int. 2008 Jan; 101(2):170-4.
    View in: PubMed
    Score: 0.009
  33. Population-based case-control study of PSA and DRE screening on prostate cancer mortality. Urology. 2007 Nov; 70(5):936-41.
    View in: PubMed
    Score: 0.009
  34. Correlating routine cytology, quantitative nuclear morphometry by digital image analysis, and genetic alterations by fluorescence in situ hybridization to assess the sensitivity of cytology for detecting pancreatobiliary tract malignancy. Am J Clin Pathol. 2007 Aug; 128(2):272-9.
    View in: PubMed
    Score: 0.008
  35. Diagnosis of obesity by primary care physicians and impact on obesity management. Mayo Clin Proc. 2007 Aug; 82(8):927-32.
    View in: PubMed
    Score: 0.008
  36. Histopathologic grading of adult medulloblastomas. Cancer. 2007 Jun 15; 109(12):2557-65.
    View in: PubMed
    Score: 0.008
  37. Is the GPSM scoring algorithm for patients with prostate cancer valid in the contemporary era? J Urol. 2007 Aug; 178(2):459-63; discussion 463.
    View in: PubMed
    Score: 0.008
  38. Assessment of changes in kidney allograft function using creatinine-based estimates of glomerular filtration rate. Am J Transplant. 2007 Apr; 7(4):880-7.
    View in: PubMed
    Score: 0.008
  39. Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomy. Mayo Clin Proc. 2007 Apr; 82(4):422-7.
    View in: PubMed
    Score: 0.008
  40. Long-term success of antegrade endopyelotomy compared with pyeloplasty at a single institution. J Endourol. 2006 Oct; 20(10):707-12.
    View in: PubMed
    Score: 0.008
  41. Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy. Urology. 2006 Sep; 68(3):604-8.
    View in: PubMed
    Score: 0.008
  42. Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy. J Urol. 2006 Sep; 176(3):1118-21.
    View in: PubMed
    Score: 0.008
  43. Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significance. J Urol. 2006 Aug; 176(2):559-63.
    View in: PubMed
    Score: 0.008
  44. Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001. Cancer. 2006 Jun 15; 106(12):2630-5.
    View in: PubMed
    Score: 0.008
  45. Impact of patient age at treatment on outcome following radical retropubic prostatectomy for prostate cancer. J Urol. 2006 Mar; 175(3 Pt 1):952-7.
    View in: PubMed
    Score: 0.008
  46. Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival. J Urol. 2006 Feb; 175(2):547-51.
    View in: PubMed
    Score: 0.008
  47. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int. 2006 Feb; 69(4):760-4.
    View in: PubMed
    Score: 0.008
  48. Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int. 2006 Jan; 69(2):399-405.
    View in: PubMed
    Score: 0.008
  49. Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy. J Urol. 2005 Dec; 174(6):2191-6.
    View in: PubMed
    Score: 0.008
  50. Effect of energy-reduced diets high in dairy products and fiber on weight loss in obese adults. Obes Res. 2005 Aug; 13(8):1344-53.
    View in: PubMed
    Score: 0.007
  51. Decline in the overall incidence of regional-distant prostate cancer in Olmsted County, MN, 1980-2000. BJU Int. 2005 May; 95(7):951-5.
    View in: PubMed
    Score: 0.007
  52. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol. 2005 Apr; 173(4):1121-5.
    View in: PubMed
    Score: 0.007
  53. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int. 2005 Apr; 95(6):751-6.
    View in: PubMed
    Score: 0.007
  54. Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation. Am J Kidney Dis. 2005 Jan; 45(1):102-11.
    View in: PubMed
    Score: 0.007
  55. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004 Dec 21; 141(12):929-37.
    View in: PubMed
    Score: 0.007
  56. Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy. J Urol. 2004 Dec; 172(6 Pt 1):2244-8.
    View in: PubMed
    Score: 0.007
  57. The impact of surgical approach (nerve bundle preservation versus wide local excision) on surgical margins and biochemical recurrence following radical prostatectomy. J Urol. 2004 Oct; 172(4 Pt 1):1328-32.
    View in: PubMed
    Score: 0.007
  58. ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers. Genes Chromosomes Cancer. 2004 Sep; 41(1):1-11.
    View in: PubMed
    Score: 0.007
  59. Surgical treatment for local control of female urethral carcinoma. Urol Oncol. 2004 Sep-Oct; 22(5):404-9.
    View in: PubMed
    Score: 0.007
  60. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J Urol. 2003 Nov; 170(5):1872-6.
    View in: PubMed
    Score: 0.007
  61. Urinary albumin to osmolality ratio predicts 24-hour urine albumin excretion in diabetes mellitus. Am J Kidney Dis. 2003 Oct; 42(4):685-92.
    View in: PubMed
    Score: 0.007
  62. Long-term study of the ultrastructural changes of myocardium in patients undergoing cardiac surgery, with more than 10 years follow-up. Int J Cardiol. 1983 Sep; 4(2):153-68.
    View in: PubMed
    Score: 0.006
  63. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers. Cancer. 2003 Jan 01; 97(1):1-11.
    View in: PubMed
    Score: 0.006
  64. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy. Cancer. 2002 Sep 15; 95(6):1215-9.
    View in: PubMed
    Score: 0.006
  65. Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival. J Urol. 2002 Sep; 168(3):1204-11.
    View in: PubMed
    Score: 0.006
  66. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. J Urol. 2002 Aug; 168(2):525-9.
    View in: PubMed
    Score: 0.006
  67. TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors. Cancer Res. 2002 Jul 01; 62(13):3587-91.
    View in: PubMed
    Score: 0.006
  68. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables. J Urol. 2002 Jan; 167(1):117-22.
    View in: PubMed
    Score: 0.006
  69. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression. Mod Pathol. 2002 Jan; 15(1):35-44.
    View in: PubMed
    Score: 0.006
  70. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol. 2001 Oct 01; 19(19):3938-43.
    View in: PubMed
    Score: 0.006
  71. Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. Urology. 2001 Jun; 57(6):1033-7.
    View in: PubMed
    Score: 0.006
  72. Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol. 2001 Apr; 165(4):1146-51.
    View in: PubMed
    Score: 0.005
  73. Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy. J Clin Oncol. 2000 Aug; 18(15):2862-8.
    View in: PubMed
    Score: 0.005
  74. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol. 2000 Jul; 164(1):101-5.
    View in: PubMed
    Score: 0.005
  75. Extranodal extension in lymph node-positive prostate cancer. Mod Pathol. 2000 Feb; 13(2):113-8.
    View in: PubMed
    Score: 0.005
  76. Fluorescence in situ hybridization aneuploidy as a predictor of clinical disease recurrence and prostate-specific antigen level 3 years after radical prostatectomy. Mayo Clin Proc. 1999 Dec; 74(12):1214-20.
    View in: PubMed
    Score: 0.005
  77. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer. 1999 Nov 01; 86(9):1775-82.
    View in: PubMed
    Score: 0.005
  78. Dedifferentiation in the metastatic progression of prostate carcinoma. Cancer. 1999 Aug 15; 86(4):657-63.
    View in: PubMed
    Score: 0.005
  79. Prevalence and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy. Am J Surg Pathol. 1999 Jul; 23(7):803-8.
    View in: PubMed
    Score: 0.005
  80. Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy. Urology. 1999 Jul; 54(1):105-10.
    View in: PubMed
    Score: 0.005
  81. Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison. J Urol. 1999 Apr; 161(4):1223-7; discussion 1227-8.
    View in: PubMed
    Score: 0.005
  82. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer. J Urol. 1999 Apr; 161(4):1229-32.
    View in: PubMed
    Score: 0.005
  83. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery. J Urol. 1999 Apr; 161(4):1233-7.
    View in: PubMed
    Score: 0.005
  84. p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy. Cancer. 1999 Mar 15; 85(6):1293-9.
    View in: PubMed
    Score: 0.005
  85. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol. 1999 Mar; 161(3):857-62; discussion 862-3.
    View in: PubMed
    Score: 0.005
  86. Cancer volume of lymph node metastasis predicts progression in prostate cancer. Am J Surg Pathol. 1998 Dec; 22(12):1491-500.
    View in: PubMed
    Score: 0.005
  87. Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy. Cancer. 1998 Nov 15; 83(10):2164-71.
    View in: PubMed
    Score: 0.005
  88. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology. 1997 Nov; 113(5):1449-56.
    View in: PubMed
    Score: 0.004
  89. Preoperative androgen-deprivation therapy for clinical stage T3 prostate cancer. Semin Urol Oncol. 1997 Nov; 15(4):222-9.
    View in: PubMed
    Score: 0.004

© 2024 Kaiser Permanente